MedPath

Ketodex Efficacy for adult procedural sedatio

Phase 3
Recruiting
Conditions
Adult procedural sedation.
Registration Number
IRCT20130108012072N13
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
135
Inclusion Criteria

Patients with pain severity status of Anesthesiology physical status I to III (ASA I-III),
Visual Analog Scale>4

Exclusion Criteria

?Addiction to drugs and analgesics
Use of analgesics in 24 hours ego
Underlying disease such as hypertension, liver and kidney disease)
Pregnancy
Psychiatric disease such as psychosis
Severe verbal or hearing disability
Sensitivity to Ketamine, Ketofol and Ketodex

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain severity score with Visual Analog Scale. Timepoint: Study beginning, 30 minutes and 1 hour and 2 hours after treatment. Method of measurement: Visual Analog Scale.;Sedation level with Ramsay Sedation Score (RASS). Timepoint: Study beginning, 30 minutes and 1 hour and 2 hours after treatment. Method of measurement: Ramsay Sedation Score (RASS).
Secondary Outcome Measures
NameTimeMethod
Hemodynamic changes. Timepoint: Study beginning, 30 minutes and 1 hour and 2 hours after treatment. Method of measurement: Manometer; Heart rate; Pulseoximetry.;Agitation. Timepoint: Study beginning, 30 minutes and 1 hour and 2 hours after treatment. Method of measurement: Checklist.
© Copyright 2025. All Rights Reserved by MedPath